Charles Ornstein: Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their ResearchMarch 2014
The conflict of interest between pharmaceuticals and clinical trials.
Charles Ornstein: Ad Endorsing da Vinci Robot Violated U of Illinois PoliciesMarch 2014
When surgical team members endorsed the robot in an ad, controversy ensued.
Charles Ornstein and Tracy Weber: Generic or Name Brand?November 2013
With billions in potential savings for Medicare at stake, we asked drug experts and practitioners alike why more doctors don’t recommend generics when they can.
Lewis H. Lapham: Memento MoriSeptember 2013
The death of American exceptionalism—and of me.
Michael Grabell: The $13 Test That Saved My Baby’s LifeSeptember 2013
Why isn’t required for every newborn?
Tracy Weber, Charles Ornstein and Jennifer LaFleur: ‘Extreme’ PrescribersJune 2013
An Inspector General’s report faults Medicare for not tracking abuses in prescriptions.
Charles Seife and Rob Garver: FDA Approved New Drug Despite Ongoing Investigation of Lab MisconductApril 2013
Though agents found blatant fraud in a Houston lab, the FDA refused to question drug safety.
Robert Garver and Charles Seife: Double DoseApril 2013
In a second case of flawed drug research, FDA response was slow and secretive.
Jeff Gerth: “Burn the Data”March 2013
Did a company try to hide risks of MRI dye Omniscan?
Blair Hickman: When Doctors Feel Pain After a Medical MistakeJanuary 2013
The best remedy is transparency.
Marshall Allen: What a New Doctor Learned About Medical Mistakes From Her Mom’s DeathJanuary 2013
A personal encounter with the complexity and errors of the modern healthcare system.
Marshall Allen: Death on the Operating TableNovember 2012
Journalist Mina Kimes discusses illegal drug experiments and medical catastrophe.
Roslyn Bernstein: Frank Moore’s Dark ThoughtsNovember 2012
“Toxic Beauty,” a retrospective at NYU’s Grey Gallery, brings together the writing and visual work of an extraordinarily socially engaged artist.